References
S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 101, 364–389 (2016)
K. Løvås, E.S. Husebye, Continuous subcutaneous hydrocortisone infusion in Addison’s disease. Eur. J. Endocrinol. 157, 109–112 (2007)
M. Øksnes, S. Bensing, A.L. Hulting, O. Kämpe, A. Hackemann, G. Meyer, K. Badenhoop, C. Betterle, A. Parolo, R. Giordano, A. Falorni, L. Papierska, W. Jeske, A.A. Kasperlik-Zaluska, V.K. Chatterjee, E.S. Husebye, K. Løvås, Quality of life in European patients with Addison’s disease: Validity of the disease-specific questionnaire AddiQoL. J. Clin. Endocrinol. Metab. 97, 568–576 (2012)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
AF declares that he has received a speaker honorarium from Shire Italy S.p.A. The remaining authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from the patient included in the study.
Rights and permissions
About this article
Cite this article
Cardini, F., Torlone, E., Bini, V. et al. Continuous subcutaneous hydrocortisone infusion in a woman with secondary adrenal insufficiency. Endocrine 63, 398–400 (2019). https://doi.org/10.1007/s12020-018-1780-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-018-1780-4